Shared Decision-Making in MS: Improving Patient Engagement
and Collaboration. An Animated Whiteboard Program

View Activity

FACULTY

Patricia Coyle, MD
Professor, Department of Neurology
Vice Chair, Clinical Affairs
Director, MS Comprehensive Care Center
Stony Brook Medicine
Stony Brook, New York

PROGRAM OVERVIEW

This enduring activity is focused on the care of patients with multiple sclerosis.

TARGET AUDIENCE

This CME initiative is designed to meet the needs of physicians, specialists, nurses, nurse practitioners, and other
health care professionals treating patients with MS.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Review the role of shared decision-making (SDM) in designing treatment plans and long-term care for patients with MS
  • Identify ways to improve patients’ engagement in their MS care through review of preferences, goals, and individual circumstances
  • Assess treatment options for MS along with their roles in the individualized treatment of MS

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit TM . Physicians should claim only the credit commensurate with the extent of their participation in the online activity.

Nursing Credit Information
Purpose: This program would be beneficial for nurses involved in the care of patients with multiple sclerosis.
Credits: 1.0 ANCC Contact Hour

CNE Accreditation Statement
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education for RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the
manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Patricia Coyle, MD, has received consultant fees from Accordant, Bayer, Biogen, Celgene, Genentech/Hoffman LaRoche,
Novartis, Sanofi Genzyme, and Serono; and research funding from Actelion, Alkermes, Genentech/Hoffman LaRoche,
MedDay, NINDS, and Novartis.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.

Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.

Felecia Beachum, Program Manager for Med Learning Group, has nothing to disclose.

Stephanie Wenick, Medical Director for Med Learning Group, has nothing to disclose.

Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.

Brianna Hanson, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit participants must:

  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the online activity.
  3. Submit the evaluation form to Med Learning Group.

You will receive your certification as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making skills before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement
information at https://www.medlearninggroup.com/privacy-policy/

RELEASE DATE: August 26, 2019

EXPIRATION DATE: August 26, 2020

View Activity

Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.